Compare MRNA & EQX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRNA | EQX |
|---|---|---|
| Founded | 2010 | 2007 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 10.9B |
| IPO Year | 2018 | N/A |
| Metric | MRNA | EQX |
|---|---|---|
| Price | $25.14 | $13.75 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 1 |
| Target Price | ★ $33.91 | $17.00 |
| AVG Volume (30 Days) | ★ 10.0M | 9.6M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | $2,232,000,000.00 | ★ $2,296,356,000.00 |
| Revenue This Year | N/A | $69.47 |
| Revenue Next Year | $0.77 | $50.55 |
| P/E Ratio | ★ N/A | $120.99 |
| Revenue Growth | N/A | ★ 85.65 |
| 52 Week Low | $22.28 | $4.95 |
| 52 Week High | $48.92 | $14.27 |
| Indicator | MRNA | EQX |
|---|---|---|
| Relative Strength Index (RSI) | 50.59 | 64.44 |
| Support Level | $23.92 | $13.53 |
| Resistance Level | $26.00 | $14.27 |
| Average True Range (ATR) | 1.19 | 0.60 |
| MACD | 0.09 | 0.11 |
| Stochastic Oscillator | 72.59 | 79.12 |
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Equinox Gold Corp is a mining company engaged in the operation, acquisition, exploration, and development of mineral properties, with a focus on gold. Equinox Gold has around seven operating gold mines and a clear plan to increase production by advancing the pipeline of growth projects. Geographically, the company operates in the United States, Mexico, and Brazil. The majority of its revenue is generated from Canada.